Curis inc cnn
WebCRIS Stock 12 Months Forecast. Based on 2 Wall Street analysts offering 12 month price targets for Curis in the last 3 months. The average price target is $7.00 with a high …
Curis inc cnn
Did you know?
WebJan 3, 2024 · /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today... WebApr 6, 2024 · Curis, Inc. was incorporated in 2000 and is headquartered in Lexington, Massachusetts. Rewards. Risk analysis. Earnings are forecast to decline by an average of 9.9% per year for the next 3 years. Currently unprofitable and not forecast to become profitable over the next 3 years. Volatile share price over the past 3 months.
WebAug 30, 2024 · Curis, Inc. Common Stock (CRIS) Nasdaq Listed. 2. Out Of Compliance +1 more notification. Add to Watchlist. Add to Portfolio. CRIS CRIS NEWS HEADLINES. WebFind real-time FIXX - Homology Medicines Inc stock quotes, company profile, news and forecasts from CNN Business. FIXX - Homology Medicines Inc Stock quote - …
WebMay 12, 2024 · First Quarter 2024 Financial Results. For the first quarter of 2024, Curis reported a net loss of $9.9 million or $0.11 per share on both a basic and diluted basis, … WebAug 4, 2024 · Curis management will host a conference call today, August 4, 2024, at 4:30 p.m. ET, to discuss these financial results, as well as provide a corporate update. To access the live conference call ...
WebCuris Inc (NASDAQ:CRIS) 0.59 Delayed Data As of Apr 04 +0.0137 / +2.40% Today’s Change 0.47 Today 52-Week Range 1.77 +7.27% Year-to-Date Quote Profile News Charts Forecasts Financials...
WebMar 31, 2024 · About Curis, Inc. Curis is a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer. In 2015, Curis entered into a collaboration with Aurigene in the areas of immuno-oncology and precision oncology. As part of this collaboration, Curis has exclusive licenses to oral small molecule … can herbalists prescribeWebJun 11, 2024 · Curis Inc (NASDAQ:CRIS) has announced updated data from its ongoing Phase 1/2 study of CA-4948 in patients with acute myeloid leukemia (AML) or high-risk myelodysplastic syndromes (MDS). Key... can herbalife shakes cause weight gainWebOct 7, 2024 · About Curis, Inc. Curis is a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer. In 2015, Curis entered into a collaboration with Aurigene in ... fit for duty physical near meWebThe 4 analysts offering 12-month price forecasts for Seelos Therapeutics Inc have a median target of 4.00, with a high estimate of 11.00 and a low estimate of 3.00. The median estimate represents ... fit for duty policy oshaWebCuris, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. fit for duty policy canadaWebCuris, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA … fit for duty policy albertaWebFind real-time MED - Medifast Inc stock quotes, company profile, news and forecasts from CNN Business. can herbal life cause high blood sugar